Business ❯ Corporate Strategy ❯ Market Expansion

Acquisitions

Strategic Partnerships Bang Energy Tilray Brands Growth Opportunities Drug Development Healthcare Sector Sustainability Initiatives Industry Leaders BioMarin Pharmaceutical Financial Investments Regulatory Approval Mergers and Acquisitions Terns Pharmaceuticals Consumer Behavior Global Gaming Market Renk

BioMarin to Buy Alesta for $275 Million to Add Oral HPP Drug

Funded from cash on hand, the purchase brings ALE1 into BioMarin’s rare-skeletal portfolio, signaling a push to scale clinical-stage therapies.

Pfizer to Buy Metsera in Up to $7.3 Billion Obesity Bet

Blog Terms of Service Privacy Policy Help Partners About Us

Copyright © 2026 Mina Labs Inc.